• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Baxter

Baxter issues serious correction for large-volume infusion pump

June 9, 2025 By Sean Whooley

The FDA has warned of a serious potential issue with Novum IQ large-volume infusion pumps made by Baxter . Our sister site, Drug Delivery Business News, reports today that Baxter recently warned customers of the potential for underinfusion with the pump. According to the FDA’s notice, keeping the administration set loaded in the pump for an […]

Filed Under: Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: Baxter, FDA

Former Baxter kidney unit Vantive to invest $1B in digitally enabled therapies

June 2, 2025 By Sean Whooley

Vantive, the former kidney care unit of Baxter, today announced plans to invest more than $1 billion in new technology over the next five years. The business, which Baxter sold to a private equity firm for nearly $4 billion, plans to use the investment to expand R&D and production capacity. It hopes to fuel innovation […]

Filed Under: Business/Financial News, Dialysis, Digital Health, Health Technology, Patient Monitoring, Research & Development, Software / IT Tagged With: Baxter, Vantive

Baxter launches room-temperature collagen sealing pad

May 20, 2025 By Sean Whooley

Baxter announced today that it launched its latest Hemopatch sealing hemostat pad. The room-temperature collagen pad, approved for hemostasis and sealing, features an extended shelf life of three years. It involves the interaction of two components that can create rapid and lasting hemostasis by sealing off the bleeding surface. Preclinical studies have shown that patch […]

Filed Under: Featured, Surgical, Wound Care Tagged With: Baxter

BD files patent infringement lawsuit against Baxter over infusion pump tech

May 13, 2025 By Sean Whooley

BD (NYSE:BDX) has alleged patent infringement by Baxter (NYSE:BAX) in a new legal complaint related to infusion pump technology. Our sister site, Drug Delivery Business News, reports today that BD filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025, alleging the “infringing manufacture, use, importation, offer for sale, […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Legal News, Patent Infringement Tagged With: Baxter, BD

Baxter beats the Street in Q1, increases full-year guidance

May 1, 2025 By Jim Hammerand

Baxter today reported first quarter results that exceeded expectations. The Deerfield, Illinois–based medtech company reported sales of $2.63 billion for the first quarter (ended March 31), up 5% from the same quarter a year ago. Adjusted earnings per share (EPS) came in at $0.55. Those results beat Wall Street analysts’ expectations for adjusted EPS of […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Baxter, import taxes, tariffs, taxes

Medtech stocks sink in trade war

April 7, 2025 By Chris Newmarker

The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the Trump administration’s new global trade war. The S&P 500 briefly entered bear market territory today as it swung wildly in response to chaotic news reports about what the administration and other countries […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Abbott, AdvaMed, Baxter, BD, Boston Scientific, Donald Trump, GE Healthcare, Intuitive, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, Stryker, Trump Administration, Zimmer Biomet

Baxter stock rises on Street-beating, better-than-expected Q4

February 20, 2025 By Sean Whooley

Baxter shares rose today on fourth-quarter results that came in ahead of the consensus forecast. Shares of BAX ticked up 8% to $33.29 apiece in midday trading today. The Deerfield, Illinois–based medtech company reported losses of $512 million. That equals $1 per share on results from both continuing operations and discontinued operations. Baxter recorded sales […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Baxter

Baxter CEO Almeida to retire, Kidney Care business becomes standalone company

February 3, 2025 By Sean Whooley

Baxter announced today that José (Joe) E. Almeida, its chair, president and CEO, plans to retire, effective immediately. The company also announced the appointment of a new chief operating officer and that its former Kidney Care business now stands alone as “Vantive.” Almeida retired from all his executive roles but plans to serve in an […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Personnel Moves, Vantive

The biggest medtech M&A moves of 2024

December 27, 2024 By Sean Whooley

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Axonics, Baxter, BD, Boston Scientific, Carl Zeiss Meditec, Carlyle Group, Edwards Lifesciences, Johnson & Johnson, Johnson & Johnson MedTech, Owens & Minor, Rotech Healthcare, Shockwave Medical, Silk Road Medical, V-Wave

Layoffs in medtech: These companies recently reduced their workforce

December 6, 2024 By Sean Whooley

Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]

Filed Under: Business/Financial News, Featured, In-Depth Coverage, MassDevice Earnings Roundup, Special Content, Wall Street Beat Tagged With: 3m, Accuray, Acutus Medical, Akili Interactive Labs, Ambu, Baxter, BD, Better Therapeutics, Boston Scientific, Butterfly Network, Cala Health, Cook Medical, Cue Health, Dentsply Sirona, iCad Inc., ICU Medical, Illumina, Johnson & Johnson MedTech, LivaNova, Nevro Corp., Pear Therapeutics, Philips, Retractable Technologies, Siemens Healthineers, Surgalign, Surmodics, Titan Medical, Venus Concept, Verily, Vicarious Surgical, Zimmer Biomet

Baxter expects $200M hit from hurricane, decreases full-year forecast

November 8, 2024 By Jim Hammerand

Baxter (NYSE: BAX) today said it expects to lose out on at least $200 million worth of sales due to flooding at its North Cove manufacturing facility from Hurricane Helene. That estimate — which includes about $40 million to $50 million worth of Kidney Care sales and around $150 million to $160 million worth of […]

Filed Under: Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Baxter, Carlyle Group, Vantive

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 42
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy